Allergies News and Research

Latest Allergies News and Research

Unhealthy air increases the chances of catching COVID-19

A Swedish study published in the journal JAMA Network Open investigates the association between short-term exposure to air pollution and SARS-CoV-2 infection.

26 Apr 2022

Common subcutaneous antibody therapy for immunodeficient patients has anti-SARS-CoV-2 antibodies

Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS--COV-2 in a common subcutaneous antibody therapy (Hizentra) used to treat immunocompromised or immunodeficient patients, citing its protective benefits to the immunocompromised patient community.

25 Apr 2022

Monoclonal-antibody combination AZD7442 prevents COVID-19

In a recent study published in The New England Journal of Medicine, the researchers examined the monoclonal-antibody combination AZD7442 to prevent coronavirus disease 2019 (COVID-19).

25 Apr 2022

Study reveals a complexity to how the body "regulates the regulators" of the immune system

Checkpoint inhibitors have become important tools in the cancer-fighting arsenal. By blocking proteins that normally restrain the immune response, these drugs can help the immune system destroy cancer cells.

20 Apr 2022

Better ventilation can prevent covid spread. But are companies paying attention?

Americans are abandoning their masks. They're done with physical distancing. And, let's face it, some people are just never going to get vaccinated.

19 Apr 2022

Manipulating a specific gene from yeast could lead a new approach to combatting drug resistance

A recent study that shows manipulating and deleting a specific gene (AMN1) from yeast could provide a foundation for a new approach to combatting drug resistance when treating microbial infections or cancer.

18 Apr 2022

Researchers track COVID-fighting antibodies after vaccination

The antibodies generated by Pfizer's COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from UVA Health.

15 Apr 2022

Patients with allergic disorders have greater risk of high blood pressure and coronary heart disease

Data from the National Health Interview Survey demonstrated adults with a history of allergic disorders have an increased risk of high blood pressure and coronary heart disease, with the highest risk seen in Black male adults.

11 Apr 2022

Alternative anti-HIV strategy generates promising results in a phase I clinical trial

vaccines against the virus, but unfortunately, HIV has numerous defense mechanisms that prevent a person's immune system from mounting an effective response following HIV vaccination.

11 Apr 2022

Researchers obtain a treasure trove of new data about RNA viruses from ocean water samples

Ocean water samples collected around the world have yielded a treasure trove of new data about RNA viruses, expanding ecological research possibilities and reshaping our understanding of how these small but significant submicroscopic particles evolved.

7 Apr 2022

Researchers reveal why people with allergic asthma are protected from severe COVID

The vast majority of people infected with the omicron variant of SARS-CoV-2 experience mild cold-like symptoms, moderate flu-like symptoms, or no symptoms at all, but the virus is so transmissible that it still spread deep into lung tissue to cause severe disease and death in thousands of people in the United States in 2022 alone.

7 Apr 2022

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

A new study illustrated the association of immunoglobulins with blood characteristics in COVID-19 patients.

6 Apr 2022

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The SAVE initiative assesses the impact of SARS-CoV-2 variants on diagnostics, vaccines, and therapies, as well as communicating public health dangers.

4 Apr 2022

The effect of COVID-19 on the lung function of young adults

Researchers evaluate whether SARS-CoV-2 infection has a negative impact on lung function in young adults who experienced mild to moderate COVID-19.

3 Apr 2022

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

In a paper in the journal Nature, Los Alamos National Laboratory scientists Bette Korber, Hyejin Yoon, Will Fischer and James Theiler, among nearly 130 authors from institutions around the world, describe their groundbreaking collaborative work, "Defining the risk of SARS-CoV-2 variants on immune protection."

1 Apr 2022

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Connie Houtz didn't think covid would be that bad. She'd seen many people in this rural hamlet in central Pennsylvania get infected yet recover within a few days. She did not get vaccinated because she worried about how a new vaccine, developed in record time, might affect her heart condition.

1 Apr 2022

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

31 Mar 2022

Allergies News and Research

Latest Allergies News and Research

Unhealthy air increases the chances of catching COVID-19

Common subcutaneous antibody therapy for immunodeficient patients has anti-SARS-CoV-2 antibodies

Monoclonal-antibody combination AZD7442 prevents COVID-19

Study reveals a complexity to how the body "regulates the regulators" of the immune system

Better ventilation can prevent covid spread. But are companies paying attention?

Manipulating a specific gene from yeast could lead a new approach to combatting drug resistance

Researchers track COVID-fighting antibodies after vaccination

Patients with allergic disorders have greater risk of high blood pressure and coronary heart disease

Alternative anti-HIV strategy generates promising results in a phase I clinical trial

Researchers obtain a treasure trove of new data about RNA viruses from ocean water samples

Researchers reveal why people with allergic asthma are protected from severe COVID

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The effect of COVID-19 on the lung function of young adults

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

Study sheds light on biomechanistic reasons why allergic asthma correlates with milder forms of COVID-19

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Allergies News and Research

Latest Allergies News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in